Like The Herald Business Journal on Facebook!
The Herald of Everett, Washington
Customer service  |  Subscribe   |   Log in or sign up   |   Advertising information   |   Contact us
Heraldnet.com

The top local business stories in your email

Contact Us:

Josh O'Connor
Publisher
Phone: 425-339-3007
joconnor@heraldnet.com

Maureen Bozlinski
General Sales Manager
Phone: 425-339-3445
Fax: 425-339-3049
mbozlinksi@heraldnet.com

Jim Davis
Editor
Phone: 425-339-3097
jdavis@heraldnet.com

Site address:
1800 41st Street, S-300,
Everett, WA 98203

Mailing address:
P.O. Box 930
Everett, WA 98206

HBJ RSS feeds

Pfizer laying off some U.S. sales representatives

SHARE: facebook Twitter icon Linkedin icon Google+ icon Email icon |  PRINTER-FRIENDLY  |  COMMENTS
Associated Press
Published:
NEW YORK -- Drugmaker Pfizer Inc. is starting another round of layoffs, targeting U.S. sales representatives who promote Pfizer primary care medicines to doctors.
The New York-based Viagra maker isn't giving details on how many salespeople it employs, how many will leave or when that will happen. Individual salespeople haven't been notified whether they'll be furloughed.
A Pfizer spokesman confirms changes are coming but says details about the sales force are proprietary.
In a statement, the world's biggest drugmaker says it continually evaluates how to be more efficient and best allocate money and staff to serve customers.
Generic competition to popular drugs such as Pfizer's cholesterol blockbuster Lipitor means they're not promoted anymore. But reps are needed to promote a big anticlotting drug awaiting approval and current big sellers like pain treatment Lyrica.

MORE HBJ HEADLINES

CALENDAR

Share your comments: Log in using your HeraldNet account or your Facebook, Twitter or Disqus profile. Comments that violate the rules are subject to removal. Please see our terms of use. Please note that you must verify your email address for your comments to appear.

You are logged in using your HeraldNet ID. Click here to update your profile. | Log out.

Our new comment system is not supported in IE 7. Please upgrade your browser here.

comments powered by Disqus

Market roundup